Evidence map›Paper›PMID 33810921›Full record

Trial reportEuropean urology2021

Shockwave Lithotripsy Versus Ureteroscopic Treatment as Therapeutic Interventions for Stones of the Ureter (TISU): A Multicentre Randomised Controlled Non-inferiority Trial.

Ranan Dasgupta, Sarah Cameron, Lorna Aucott, Graeme MacLennan, Ruth E Thomas, Mary M Kilonzo, Thomas B L Lam, James N'Dow, John Norrie, Ken Anson and 6 more

Open access · hybridAbstract readMulticenter StudyRandomized Controlled TrialPragmatic Clinical Trial
In one paragraph

Trial report in European urology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed, 2 pooled it
4.0field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 2 syntheses or guidelines pooled it, 41 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Trial
  5. Article
  6. Article
  7. Article
  8. Extracorporeal shockwavelithotripsyWorld journal of critical care medicine · 2026
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

16 authors at 9 institutions in 1 country.

Ranan DasguptaDepartment of Urology, Imperial College Healthcare NHS Trust, London, W2 1NY, UK. Electronic address: ranan.dasgupta1@nhs.net.
Sarah CameronCentre for Healthcare Randomised Trials, University of Aberdeen, Health Sciences Building, Foresterhill, Aberdeen, UK.
Lorna AucottHealth Services Research Unit, University of Aberdeen, Health Sciences Building, Foresterhill, Aberdeen, UK.
Graeme MacLennanCentre for Healthcare Randomised Trials, University of Aberdeen, Health Sciences Building, Foresterhill, Aberdeen, UK.
Ruth E ThomasCentre for Healthcare Randomised Trials, University of Aberdeen, Health Sciences Building, Foresterhill, Aberdeen, UK.
Mary M KilonzoHealth Economics Research Unit, University of Aberdeen, Aberdeen, UK.
Thomas B L LamNHS Grampian, Department of Urology, Aberdeen Royal Infirmary, Aberdeen, UK; Academic Urology Unit, University of Aberdeen, Health Sciences Building, Foresterhill, Aberdeen, UK.
James N'DowNHS Grampian, Department of Urology, Aberdeen Royal Infirmary, Aberdeen, UK.
John NorrieEdinburgh Clinical Trials Unit, Usher Institute of Population Health Sciences & Informatics, University of Edinburgh, Edinburgh, UK.
Ken AnsonDepartment of Urology, St Georges University Hospitals NHS Foundation Trust, London, UK.
Neil BurgessDepartment of Urology, Norfolk and Norwich University Hospitals NHS Foundation Trust, Norwich, UK.
Charles T ClarkStone Patient Advisory Group, Section of Endourology, British Association of Urological Surgeons, London, UK.
Francis X KeeleyBristol Urological Institute, North Bristol NHS Trust, Bristol, UK.
Sara J MacLennanAcademic Urology Unit, University of Aberdeen, Health Sciences Building, Foresterhill, Aberdeen, UK.
Kath StarrNottingham Clinical Trials Unit, University of Nottingham, University Park, Nottingham, UK.
Sam McClintonNHS Grampian, Department of Urology, Aberdeen Royal Infirmary, Aberdeen, UK.
University of Aberdeen · GBAberdeen Royal Infirmary · GBBritish Association of Urological Surgeons · GBImperial College Healthcare NHS Trust · GBNorfolk and Norwich University Hospitals NHS Foundation Trust · GBNorth Bristol NHS Trust · GBSt George’s University Hospitals NHS Foundation Trust · GBUniversity of Edinburgh · GBUniversity of Nottingham · GB

Funding

Chief Scientist Office HERU1Chief Scientist Office HSRU1Department of Health 10/137/01
6 · The paper itself

Abstract

backgroundRenal stone disease is common and can cause emergency presentation with acute pain due to ureteric colic. International guidelines have stated the need for a multicentre randomised controlled trial (RCT) to determine whether a non-invasive outpatient (shockwave lithotripsy [SWL]) or surgical (ureteroscopy [URS]) intervention should be the first-line treatment for those needing active intervention. This has implications for shaping clinical pathways.

objectiveTo report a pragmatic multicentre non-inferiority RCT comparing SWL with URS. DESIGN, SETTING, AND

participantsThis trial tested for non-inferiority of up to two sessions of SWL compared with URS as initial treatment for ureteric stones requiring intervention. OUTCOME MEASUREMENTS AND STATISTICAL ANALYSIS: The primary outcome was whether further intervention was required to clear the stone, and secondary outcomes included quality of life assessment, severity of pain, and serious complications; these were based on questionnaires at baseline, 8 wk, and 6 mo. We included patients over 16 yr with a single ureteric stone clinically deemed to require intervention. Intention-to-treat and per-protocol analyses were planned. RESULTS AND LIMITATIONS: The study recruited between July 1, 2013 and June 30, 2017. We recruited 613 participants from a total of 1291 eligible patients, randomising 306 to SWL and 307 to URS. Sixty-seven patients (22.1%) in the SWL arm needed further treatment compared with 31 patients (10.3%) in the URS arm. The absolute risk difference was 11.7% (95% confidence interval 5.6%, 17.8%) in favour of URS, which was inside the 20% threshold we set for demonstrating noninferiority of SWL.

conclusionsThis RCT was designed to test whether SWL is non-inferior to URS and confirmed this; although SWL is an outpatient noninvasive treatment with potential advantages both for patients and for reducing the use of inpatient health care resources, the trial showed a benefit in overall clinical outcomes with URS compared with SWL, reflecting contemporary practice. The Therapeutic Interventions for Stones of the Ureter (TISU) study provides new evidence to help guide the choice of modality for this common health condition. PATIENT SUMMARY: We present the largest trial comparing ureteroscopy versus extracorporeal shockwave lithotripsy for ureteric stones. While ureteroscopy had marginally improved outcome in terms of stone clearance, as expected, shockwave lithotripsy had better results in terms of health care costs. These results should enable patients and health care providers to optimise treatment pathways for this common urological condition.

Indexed as

Kidney CalculiLithotripsyUreterUreteral CalculiUrinary CalculiHumansTreatment OutcomeUreteroscopyExtracorporeal shockwave lithotripsyRandomised controlled trialTherapeutic interventions for symptomatic ureteric stonesTrialUreteric stonesUreteroscopy

Identifiers

PMID33810921
PMCPMC8234516
OpenAlexW3148174177

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.